(Q36307798)

13 August 2017

1 reference

title

Surgical management of high-grade gliomas (English)

1 reference

13 August 2017

Joseph C Hsieh

1

1 reference

PubMed ID

16274269

13 August 2017

Maciej S Lesniak

series ordinal

2

1 reference

13 August 2017

1 November 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

13 August 2017

1 reference

13 August 2017

5

1 reference

13 August 2017

S33-9

1 reference

13 August 2017

6 Suppl

1 reference

Current and future strategies for the treatment of malignant brain tumors.

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Extent of resection as a prognostic variable in the treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Extent of resection in malignant gliomas: a critical summary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Value of surgical intervention in the treatment of glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

A prospective study on glioblastoma in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Reoperation for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Reoperation for malignant astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Reoperation in the treatment of recurrent intracranial malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Intraoperative compensation for brain shift.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Permanent iodine-125 implants in the up-front treatment of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Radiosurgery: a new application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

Radical surgery and reoperation in supratentorial malignant glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.S33

21 January 2018

Identifiers

DOI

10.1586/14737175.5.6.S33

1 reference

13 August 2017

1 reference

PubMed ID

16274269